In April, Indian fund managers leaned into defensive stocks, with pharmaceuticals drawing fresh inflows tied to potential upside from the semaglutide patent expiry. Mutual funds also increased focus on NBFCs and asset management companies, adding PNB Housing Finance as money tilted toward retail lending. The broader shift points to worries over oil prices and West Asian geopolitical risks.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
